Long-acting interleukin-15 receptor agonists and related immunotherapeutic compositions and methods
US12036283B2 · kind B2 · utility
0Cited by
5References
28Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 15, 2018 |
| Grant date | Jul 16, 2024 |
| Priority date | — |
| Expiry date | May 15, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The instant disclosure provides a long acting IL-15 receptor agonist, related compositions and methods of preparation and use, for example, in the treatment of conditions responsive to therapy effective to provide, for example, sustained immune activation and/or anti-tumor activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.